Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniél Vega Møller"'
Autor:
Caroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, Thomas Gerds, Clive Ballard, Daniel Vega Møller, Lotte Bjerre Knudsen, Kajsa Kvist, Bernard Zinman, Ellen Holm, Christian Torp‐Pedersen, Lina Steinrud Mørch
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 8, Iss 1, Pp n/a-n/a (2022)
Abstract Introduction People with type 2 diabetes have increased risk of dementia. Glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are among the promising therapies for repurposing as a treatment for Alzheimer's disease; a key unanswere
Externí odkaz:
https://doaj.org/article/a3a27f9ddbfd4e1cafdac0c2aea95168
Autor:
Mikhail N. Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug, Javed Butler, Louise Christensen, Melanie Davies, G. Kees Hovingh, Dalane W. Kitzman, Marie L. Lindegaard, Daniél Vega Møller, Sanjiv J. Shah, Marianne Bach Treppendahl, Subodh Verma, Mark C. Petrie
Publikováno v:
JACC. Heart failure. Elsevier BV
Background: The majority of patients with heart failure with preserved ejection fraction (HFpEF) have the obesity phenotype, but no therapies specifically targeting obesity in HFpEF exist. Objectives: The aim of this study was to describe the design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::806620b1972b6938abbac5b303fac1f2
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85161557684&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85161557684&origin=inward
Autor:
Ulrike Hövelmann, Daniela Lamers, Britta Væver Bysted, Tim Heise, Francesca Macchi, Birgit Kronshage, Daniél Vega Møller, Ulrik Mouritzen
Publikováno v:
Diabetes Care. 41:531-537
OBJECTIVE Treatment of severe hypoglycemia outside of the hospital setting is limited to glucagon formulations requiring reconstitution before use, which may lead to erroneous or delayed glucagon administration. We compared the pharmacokinetic (PK) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dad669fe5b3536a0d21f7a36b558406
https://doi.org/10.2337/dc17-1402
https://doi.org/10.2337/dc17-1402
Autor:
Richard E. Pratley, Mansoor Husain, Ildiko Lingvay, Thomas R. Pieber, Thomas Mark, Hans A. Saevereid, Daniel Vega Møller, Bernard Zinman, the DEVOTE Study Group
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-11 (2019)
Abstract Background Heart failure (HF) is a common cardiovascular complication of type 2 diabetes (T2D). This secondary analysis investigated baseline factors and treatment differences associated with risk of hospitalization for HF (hHF), and the pos
Externí odkaz:
https://doaj.org/article/a1749550eef4462cae1c6531320271cc